Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far?
Standard
Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far? / Voigtländer, Minna; Langer, Florian.
In: HAMOSTASEOLOGIE, Vol. 37, No. 4, 27.10.2017, p. 241-255.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
Voigtländer, M & Langer, F 2017, 'Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far?', HAMOSTASEOLOGIE, vol. 37, no. 4, pp. 241-255.
APA
Voigtländer, M., & Langer, F. (2017). Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far? HAMOSTASEOLOGIE, 37(4), 241-255.
Vancouver
Voigtländer M, Langer F. Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far? HAMOSTASEOLOGIE. 2017 Oct 27;37(4):241-255.
Bibtex
@article{fb8e6126ff7b430c9fd5ae792cb29d54,
title = "Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far?",
author = "Minna Voigtl{\"a}nder and Florian Langer",
year = "2017",
month = oct,
day = "27",
language = "English",
volume = "37",
pages = "241--255",
journal = "HAMOSTASEOLOGIE",
issn = "0720-9355",
publisher = "Schattauer",
number = "4",
}
RIS
TY - JOUR
T1 - Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far?
AU - Voigtländer, Minna
AU - Langer, Florian
PY - 2017/10/27
Y1 - 2017/10/27
M3 - SCORING: Journal article
C2 - 28508916
VL - 37
SP - 241
EP - 255
JO - HAMOSTASEOLOGIE
JF - HAMOSTASEOLOGIE
SN - 0720-9355
IS - 4
ER -
